Phenotypic and transcriptional fidelity of patient-Derived colon cancer xenografts in immune-deficient mice

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chou, Jeffrey ^a,b   Fitzgibbon, Matthew P ^a   Mortales, Christie Lynn L ^a   Towlerton, Andrea M H ^a   Upton, Melissa P ^c   Yeung, Raymond S ^d   McIntosh, Martin W ^a   Warren, Edus H ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; MICE; MICE, SCID;

EID: 84894287713     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079874     Document Type: Article

References (50)

1. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110. (Pubitemid 46067310)
2. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, et al. (2007) Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115. (Pubitemid 46067311)
3. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163. (Pubitemid 47175279)
4. Todaro M, Alea MP, Di Stefano AB, Cammareri P, Vermeulen L, et al. (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1: 389-402. (Pubitemid 47506537)
5. Francipane MG, Alea MP, Lombardo Y, Todaro M, Medema JP, et al. (2008) Crucial role of interleukin-4 in the survival of colon cancer stem cells. Cancer Res 68: 4022-4025.
6. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120. (Pubitemid 351872330)
7. Vermeulen L, Todaro M, de Sousa Mello F, Sprick MR, Kemper K, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105: 13427-13432.
8. Dalerba P, Kalisky T, Sahoo D, Rajendran PS, Rothenberg ME, et al. (2011) Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol 29: 1120-1127.
9. Julien S, Merino-Trigo A, Lacroix L, Pocard M, Goere D, et al. (2012) Characterization of a large panel of patient-derived tumor xenografts representing the clinical heterogeneity of human colorectal cancer. Clin Cancer Res 18: 5314-5328.
10. Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, et al. (2013) Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339: 543-548.
11. Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, et al. (2011) A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov 1: 508-523.
12. Dangles-Marie V, Pocard M, Richon S, Weiswald LB, Assayag F, et al. (2007) Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res 67: 398-407. (Pubitemid 46142799)
13. Fichtner I, Slisow W, Gill J, Becker M, Elbe B, et al. (2004) Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. Eur J Cancer 40: 298-307. (Pubitemid 38077034)
14. Guenot D, Guerin E, Aguillon-Romain S, Pencreach E, Schneider A, et al. (2006) Primary tumour genetic alterations and intra-tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability. J Pathol 208: 643-652.
15. Monsma DJ, Monks NR, Cherba DM, Dylewski D, Eugster E, et al. (2012) Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue. J Transl Med 10: 125.
16. Uronis JM, Osada T, McCall S, Yang XY, Mantyh C, et al. (2012) Histological and molecular evaluation of patient-derived colorectal cancer explants. PLoS One 7: e38422.
17. Jin K, Li G, Cui B, Zhang J, Lan H, et al. (2011) Assessment of a novel VEGF targeted agent using patient-derived tumor tissue xenograft models of colon carcinoma with lymphatic and hepatic metastases. PLoS One 6: e28384.
18. Chou J, Voong LN, Mortales CL, Towlerton AM, Pollack SM, et al. (2012) Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer. J Immunother 35: 131-141.
19. Cancer Genome Atlas N (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
20. Wu Y, Wang X, Wu F, Huang R, Xue F, et al. (2012) Transcriptome profiling of the cancer, adjacent non-tumor and distant normal tissues from a colorectal cancer patient by deep sequencing. PLoS One 7: e41001.
21. Kreso A, O'Brien CA (2008) Colon cancer stem cells. Curr Protoc Stem Cell Biol Chapter 3: Unit 3 1.
22. Cui W, Taub DD, Gardner K (2007) qPrimerDepot: a primer database for quantitative real time PCR. Nucleic Acids Res 35: D805-809. (Pubitemid 46056313)
23. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, et al. (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13: 134.
24. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, et al. (2009) Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37: e45.
25. Trapnell C, Pachter L, Salzberg SL (2009) TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25: 1105-1111.
26. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
27. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 57: 289-300.
28. Young MD, Wakefield MJ, Smyth GK, Oshlack A (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11: R14.
29. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550. (Pubitemid 41528093)
30. Yeung TM, Gandhi SC, Wilding JL, Muschel R, Bodmer WF (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A 107: 3722-3727.
31. Cheever MA, Allison JP, Ferris AS, Finn OJ, Hastings BM, et al. (2009) The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res 15: 5323-5337.
32. Kopetz S, Lemos R, Powis G (2012) The promise of patient-derived xenografts: the best laid plans of mice and men. Clin Cancer Res 18: 5160-5162.
33. Conway T, Wazny J, Bromage A, Tymms M, Sooraj D, et al. (2012) Xenome-a tool for classifying reads from xenograft samples. Bioinformatics 28: i172-178.
34. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468: 824-828.
35. Bao Q, Zhao Y, Niess H, Conrad C, Schwarz B, et al. (2012) Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer. Stem Cells Dev 21: 2355-2363.
36. Lee J, Fassnacht M, Nair S, Boczkowski D, Gilboa E (2005) Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts. Cancer Res 65: 11156-11163. (Pubitemid 41713387)
37. Wen Y, Wang CT, Ma TT, Li ZY, Zhou LN, et al. (2010) Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model. Cancer Sci 101: 2325-2332.
38. Blankenstein T (2005) The role of tumor stroma in the interaction between tumor and immune system. Current opinion in immunology 17: 180-186.
39. Kammertoens T, Schuler T, Blankenstein T (2005) Immunotherapy: target the stroma to hit the tumor. Trends in molecular medicine 11: 225-231. (Pubitemid 40692312)
40. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468: 829-833.
41. McCracken S, Kim CS, Xu Y, Minden M, Miyamoto NG (1997) An alternative pathway for expression of p56lck from type I promoter transcripts in colon carcinoma. Oncogene 15: 2929-2937. (Pubitemid 28008985)
42. Harashima N, Tanaka K, Sasatomi T, Shimizu K, Miyagi Y, et al. (2001) Recognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases. Eur J Immunol 31: 323-332. (Pubitemid 32166585)
43. Coopman PJ, Mueller SC (2006) The Syk tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett 241: 159-173. (Pubitemid 44163045)
44. Benitez AC, Dai Z, Mann HH, Reeves RS, Margineantu DH, et al. (2011) Expression, signaling proficiency, and stimulatory function of the NKG2D lymphocyte receptor in human cancer cells. Proc Natl Acad Sci U S A 108: 4081-4086.
45. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, et al. (2002) Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8: 793-800.
46. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, et al. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366: 2443-2454.
47. Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, et al. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366: 2455-2465.
48. Pawelek JM, Chakraborty AK (2008) Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis. Nat Rev Cancer 8: 377-386. (Pubitemid 351589699)
49. Powell AE, Anderson EC, Davies PS, Silk AD, Pelz C, et al. (2011) Fusion between Intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming. Cancer Res 71: 1497-1505.
50. Chang CW, Cheng WC, Chen CR, Shu WY, Tsai ML, et al. (2011) Identification of human housekeeping genes and tissue-selective genes by microarray meta-analysis. PLoS One 6: e22859.